Amanda G. Paulovich
Fred Hutchinson Cancer Center
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Lung Cancer Research Studies
Strong evidence · 1 supporting paper · latest 2026
Glioma Diagnosis and Treatment
Strong evidence · 4 supporting papers · latest 2026
Microtubule and mitosis dynamics
Solid evidence · 1 supporting paper · latest 2025
Cancer-related Molecular Pathways
Solid evidence · 1 supporting paper · latest 2025
Cancer, Hypoxia, and Metabolism
Solid evidence · 2 supporting papers · latest 2026
CAR-T cell therapy research
Solid evidence · 2 supporting papers · latest 2025
Advanced Proteomics Techniques and Applications
Solid evidence · 2 supporting papers · latest 2026
HER2/EGFR in Cancer Research
Solid evidence · 1 supporting paper · latest 2026
Publications (9)
Abstract 816: Aurora kinase A inhibition overcomes tolerance to panHER inhibitors in HPV positive HNSCC
2025DOI
Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer
2026DOIPMID 42414273
DMG-01. Protein changes in CSF as biomarkers of CAR activity and disease response in patients with DIPG treated on the BrainChild03 trial
2025DOI
Proteogenomic analysis of pediatric and AYA high-grade glioma reveals age-dependent biology, female-male differences, and kinase targets
2026DOIPMID 42753723
CTIM-03. PROTEIN CHANGES IN SERIAL CSF SAMPLES REFLECT CAR ACTIVITY, TOXICITY AND DISEASE RESPONSE IN PATIENTS WITH DIPG TREATED ON THE BRAINCHILD03 TRIAL
2025DOI
Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance
2026DOIPMID 41827907
Abstract PS2-10-17: Potential of MEK Inhibition to overcome Trastuzumab deruxtecan Resistance in MAPK-Activated Triple-Negative Breast Cancer PDX Models
2026DOI
A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights
2026DOIPMID 42013851
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study
2025DOIPMID 40382524
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Fred Hutchinson Cancer Center
Source: OpenAlex · retrieved 2026-09-29